standards > terminology artifact > DOI:10.25504/FAIRsharing.9y8f0n


ready The Potential Drug-drug Interaction and Potential Drug-drug Interaction Evidence Ontology

Abbreviation: DIDEO


General Information
A new foundational representation of potential drug-drug interactions (PDDIs) that covers the material entities and processes in the domain of discourse for PDDI evidence and knowledge claims. The representation will enable the integration of drug interaction mechanisms, effects, risk factors, severity, and management options with the chemical and pharmacological properties (e.g., chemical structure, function, pharmacokinetic and pharmacodynamic properties) of the interacting drugs. A description of the goals of the project can be found in the following workshop paper located in the docs/DIDEO-discussion-ICBO-Brochhausen-2014.pdf: Brochhausen, M., Schneider, J., Malone, D., Empey, PE., Hogan WR., and Boyce, RD. Towards a foundational representation of potential drug-drug interaction knowledge. The 1st International Drug-Drug Interaction Knowledge Representation Workshop (DIKR 2014). Collocated with the 2014 International Conference on Biomedical Ontology (ICBO 2014). October 6th, Houston, Texas. United States.

Homepage https://github.com/DIDEO/DIDEO

Developed in United States

Created in 2014

Taxonomic range




Scope and data types





How to cite this record FAIRsharing.org: DIDEO; The Potential Drug-drug Interaction and Potential Drug-drug Interaction Evidence Ontology; DOI: https://doi.org/10.25504/FAIRsharing.9y8f0n; Last edited: Feb. 22, 2018, 2:42 p.m.; Last accessed: Oct 20 2018 3:53 a.m.


This record is maintained by boycer  ORCID  and rdb20  ORCID

Record added: Dec. 27, 2016, 7:50 p.m.
Record updated: Nov. 23, 2017, 7:03 a.m. by rdb20.

Show edit history


In Collections


Support

Tools

Schemas

No XSD schemas defined


Access / Retrieve Data

Conditions of Use

Applies to: Data use




Publications

Towards a foundational representation of potential drug-drug interaction knowledge.

Brochhausen, M. Et al.
The 1st International Drug-Drug Interaction Knowledge Representation Workshop (DIKR 2014). Collocated with the 2014 International Conference on Biomedical Ontology (ICBO 2014). 2014


Conceptual models of drug-drug interactions : A summary of recent efforts

María Herrero-Zazo and Isabel Segura-Bedmar and Paloma Martínez
Knowledge-based systems 2016

View Publication

DIDEO Ontology Display

View in OBO Foundry.



Related Standards

Reporting Guidelines

No guidelines defined

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined


Implementing Databases (2)
Natural Product-Drug Interaction Research Data Repository
The Natural Product-Drug Interaction Research Data Repository, a publicly accessible database where researchers can access scientific results, raw data, and recommended approaches to optimally assess the clinical significance of pharmacokinetic natural product-drug interactions (PK-NPDIs). The repository is funded by the United States National Center for Complementary and Integrative Health.

OBO Foundry
The Open Biological and Biomedical Ontology (OBO) Foundry is a collective of ontology developers that are committed to collaboration and adherence to shared principles. The mission of the OBO Foundry is to develop a family of interoperable ontologies that are both logically well-formed and scientifically accurate. To achieve this, OBO Foundry participants voluntarily adhere to and contribute to the development of an evolving set of principles including open use, collaborative development, non-overlapping and strictly-scoped content, and common syntax and relations, based on ontology models that work well, such as the Gene Ontology (GO). The OBO Foundry is overseen by an Operations Committee with Editorial, Technical and Outreach working groups.

Implementing Policies

This record is not implemented by any policy.


Credit

Record Maintainer

Funds

Maintains

Grant Number(s)